Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria

Thioredoxin reverses age-related hypertension by chronically improving vascular redox and restoring eNOS function

(2017) Rob H. P. Hilgers et al.   Science Translational Medicine

Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression

(2016) Laura Gonzalez-Calero et al.   Cardiovascular Diabetology

Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria

(2016) H. Pulido-Olmo et al.   CLINICAL SCIENCE

Plasma Molecular Signatures in Hypertensive Patients With Renin–Angiotensin System SuppressionNovelty and Significance

(2016) Montserrat Baldan-Martin et al.   HYPERTENSION

Phagocytosis: An Immunobiologic Process

(2016) Siamon Gordon   IMMUNITY

A Novel Systems-Biology Algorithm for the Analysis of Coordinated Protein Responses Using Quantitative Proteomics

(2016) Fernando García-Marqués et al.   MOLECULAR & CELLULAR PROTEOMICS

Hypertensive patients exhibit an altered metabolism. A specific metabolite signature in urine is able to predict albuminuria progression

(2016) Laura Gonzalez-Calero et al.   Translational Research

Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis?

(2016) Laura Gonzalez-Calero et al.   Scientific Reports

Inflammation, Immunity, and Hypertensive End-Organ Damage

(2015) W. G. McMaster et al.   CIRCULATION RESEARCH

Immune Mechanisms in Arterial Hypertension

(2015) U. Wenzel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The immune system in hypertension

(2014) Daniel W. Trott et al.   ADVANCES IN PHYSIOLOGY EDUCATION

Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga

(2014) George L. Bakris et al.   DIABETES CARE

Prognostic Value of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension

(2014) Jose Maria Pascual et al.   HYPERTENSION

General Statistical Framework for Quantitative Proteomics by Stable Isotope Labeling

(2014) Pedro Navarro et al.   JOURNAL OF PROTEOME RESEARCH

Revisiting Peptide Identification by High-Accuracy Mass Spectrometry: Problems Associated with the Use of Narrow Mass Precursor Windows

(2014) Elena Bonzon-Kulichenko et al.   JOURNAL OF PROTEOME RESEARCH

KLK1 and ZG16B proteins and arginine–proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery

(2014) Marta Martin-Lorenzo et al.   Metabolomics

Blocking innate immunity to slow the progression of chronic kidney disease

(2014) Christoph Schmaderer et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) Observational Follow‐Up Study: Benefits of RAS Blockade With Olmesartan Treatment Are Sustained After Study Discontinuation

(2014) Jan Menne et al.   Journal of the American Heart Association

Calgranulins May Contribute Vascular Protection In Atherogenesis

(2013) Carolyn L. Geczy et al.   CIRCULATION JOURNAL

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis

(2013) Irene Zubiri et al.   Journal of Proteomics

Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease

(2013) Maria Posada-Ayala et al.   KIDNEY INTERNATIONAL

High-Normal Albuminuria and Risk of Heart Failure in the Community

(2011) Saul Blecker et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

The Cell Biology of Phagocytosis

(2011) Ronald S. Flannagan et al.   Annual Review of Pathology-Mechanisms of Disease

Microalbuminuria breakthrough under chronic renin–angiotensin–aldosterone system suppression

(2011) Cesar Cerezo et al.   JOURNAL OF HYPERTENSION

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

(2011) Hermann Haller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inflammation, Immunity, and Hypertension

(2010) David G. Harrison et al.   HYPERTENSION

Annexin A1: A Central Player in the Anti-Inflammatory and Neuroprotective Role of Microglia

(2010) S. McArthur et al.   JOURNAL OF IMMUNOLOGY

A Robust Method for Quantitative High-throughput Analysis of Proteomes by18O Labeling

(2010) Elena Bonzon-Kulichenko et al.   MOLECULAR & CELLULAR PROTEOMICS

APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome

(2009) Antoni Castro et al.   ATHEROSCLEROSIS

A Refined Method To Calculate False Discovery Rates for Peptide Identification Using Decoy Databases

(2009) Pedro Navarro et al.   JOURNAL OF PROTEOME RESEARCH

Dysregulation of Vascular TRPM7 and Annexin-1 Is Associated With Endothelial Dysfunction in Inherited Hypomagnesemia

(2008) Tamara M. Paravicini et al.   HYPERTENSION

Resistant Arterial Hypertension Is Associated With Higher Blood Levels of Complement C3 and C-Reactive Protein

(2008) Eli Magen et al.   Journal of Clinical Hypertension

Properties of Average Score Distributions of SEQUEST

(2008) Salvador Martínez-Bartolomé et al.   MOLECULAR & CELLULAR PROTEOMICS

STRING 8--a global view on proteins and their functional interactions in 630 organisms

(2008) L. J. Jensen et al.   NUCLEIC ACIDS RESEARCH

Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury

(2007) Neil S. Sheerin et al.   FASEB JOURNAL